{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:46:17Z","timestamp":1782801977860,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T00:00:00Z","timestamp":1202256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s12031-008-9036-z","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T19:19:03Z","timestamp":1202239143000},"page":"235-240","source":"Crossref","is-referenced-by-count":20,"title":["Association of NAD(P)H:Quinone Oxidoreductase 1 Polymorphism and Alzheimer\u2019s Disease in Chinese"],"prefix":"10.1007","volume":"34","author":[{"given":"Jian-Tao","family":"Bian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Hua","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,6]]},"reference":[{"key":"9036_CR1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H. Braak","year":"1991","unstructured":"Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica (Berl), 82, 239\u2013259.","journal-title":"Acta Neuropathologica (Berl)"},{"key":"9036_CR2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1385\/0-89603-371-6:145","volume-title":"Molecular Models of Dementia","author":"D. A. Butterfield","year":"1996","unstructured":"Butterfield, D. A., Hensley, K., Hall, N., et al. (1996). b-Amyloid-derived free radical oxidation: A fundamental process in Alzheimer\u2019s disease. In W. Wasco, & R. E. Tanzi (Eds.) Molecular Models of Dementia (pp. 145\u2013167). Totowa, NJ, USA: Humana."},{"key":"9036_CR3","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1073\/pnas.81.6.1696","volume":"81","author":"P. L. Chesis","year":"1984","unstructured":"Chesis, P. L., Levin, D. E., Smith, M. T., Ernster, L., & Ames, B. N. (1984). Mutagenicity of quinones: Pathways of metabolic activation and detoxification. Proceedings of the National Academy of Sciences of the United States of America, 81, 1696\u20131700.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9036_CR4","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/carcin\/20.7.1235","volume":"20","author":"A. Clairmont","year":"1990","unstructured":"Clairmont, A., Sies, H., Ramachandran, S., et al. (1990). Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: Use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci. Carcinogenesis, 20, 1235\u20131240.","journal-title":"Carcinogenesis"},{"key":"9036_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000077736","volume":"18","author":"O. Combarros","year":"2004","unstructured":"Combarros, O., Infante, J., Llorca, J., & Berciano, J. (2004). Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer\u2019s disease. Dementia and Geriatric Cognitive Disorders, 18, 55\u201358.","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"9036_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0076-6879(67)10059-1","volume":"10","author":"L. Ernster","year":"1967","unstructured":"Ernster, L. (1967). DT-diaphorase. Methods in Enzymology, 10, 309\u2013317.","journal-title":"Methods in Enzymology"},{"key":"9036_CR7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3891\/acta.chem.scand.12-0595","volume":"2","author":"L. Ernster","year":"1958","unstructured":"Ernster, L., & Navazio, F. (1958). Soluble diaphorase in animal tissues. Acta Chemica Scandinavica, 2, 595\u2013602.","journal-title":"Acta Chemica Scandinavica"},{"key":"9036_CR8","doi-asserted-by":"crossref","first-page":"M117","DOI":"10.1093\/gerona\/52A.2.M117","volume":"52","author":"M. Gatz","year":"1997","unstructured":"Gatz, M., Pedersen, N. L., Berg, S., et al. (1997). Heritability for Alzheimer\u2019s disease: The study of dementia in Swedish twins. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 52, M117\u2013125.","journal-title":"Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"key":"9036_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10120-004-0308-1","volume":"8","author":"Y. Goto","year":"2005","unstructured":"Goto, Y., Hamajima, N., Honda, H., et al. (2005). Association between Helicobacter pylori seropositivity and NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism observed in outpatients and health checkup examinees. Gastric Cancer, 8, 12\u201317.","journal-title":"Gastric Cancer"},{"key":"9036_CR10","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1073\/pnas.75.9.4524","volume":"75","author":"C. B. Huggins","year":"1978","unstructured":"Huggins, C. B., Ueda, N., & Russo, A. (1978). Azo dyes prevent hydrocarbon-induced leukemia in the rat. Proceedings of the National Academy of Sciences of the United States of America, 75, 4524\u20134527.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9036_CR11","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/aje\/kwm022","volume":"165","author":"C. Infante-Rivard","year":"2007","unstructured":"Infante-Rivard, C., Vermunt, J. K., & Weinberg, C. R. (2007). Excess transmission of the NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia. American Journal of Epidemiology, 165, 1248\u20131254.","journal-title":"American Journal of Epidemiology"},{"key":"9036_CR12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/bjc.1995.373","volume":"72","author":"B. L. Kuehl","year":"1995","unstructured":"Kuehl, B. L., Paterson, J. W., Peacock, J. W., Paterson, M. C., & Rauth, A. M. (1995). Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. British Journal of Cancer, 72, 555\u2013561.","journal-title":"British Journal of Cancer"},{"key":"9036_CR13","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/carcin\/21.10.1813","volume":"21","author":"M. J. Lafuente","year":"2000","unstructured":"Lafuente, M. J., Casterad, X., Trias, M., et al. (2000). NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors. Carcinogenesis, 21, 1813\u20131819.","journal-title":"Carcinogenesis"},{"key":"9036_CR14","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"M. P. Lambert","year":"1998","unstructured":"Lambert, M. P., Barlow, A. K., Chromy, B. A., et al. (1998). Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences of the United States of America, 95, 6448\u20136453.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9036_CR15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V94.2.803","volume":"94","author":"R. A. Larson","year":"1999","unstructured":"Larson, R. A., Wang, Y., Banerjee, M., et al. (1999). Prevalence of the inactivating 609C\u2192T polymorphism in the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood, 94, 803\u2013807.","journal-title":"Blood"},{"key":"9036_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0169-5002(01)00243-4","volume":"34","author":"S. J. Lewis","year":"2001","unstructured":"Lewis, S. J., Cherry, N. M., Niven, R. M., Barber, P. V., & Povey, A. C. (2001). Polymorphisms in the NAD(P)H:quinone oxidoreductase gene and small cell lung cancer risk in a UK population. Lung Cancer, 34, 177\u2013183.","journal-title":"Lung Cancer"},{"key":"9036_CR17","first-page":"2124","volume":"83","author":"Q. L. Ma","year":"2003","unstructured":"Ma, Q. L., Yang, J. F., Shao, M., Dong, X. M., & Chen, B. (2003). Association between NAD(P)H:quinone oxidoreductase and apolipoprotein E gene polymorphisms in Alzheimer\u2019s disease. Zhonghua Yi Xue Za Zhi, 83, 2124\u20132127 (in Chinese).","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"9036_CR18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G. McKhann","year":"1984","unstructured":"McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology, 34, 939\u2013944.","journal-title":"Neurology"},{"key":"9036_CR19","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1073\/pnas.96.14.8150","volume":"96","author":"J. L. Moran","year":"1999","unstructured":"Moran, J. L., Siegel, D., & Roses, D. (1999). A potential mechanism underlying the in creased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proceedings of the National Academy of Sciences of the United States of America, 96, 8150\u20138155.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9036_CR20","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","volume":"13","author":"C. J. Pike","year":"1993","unstructured":"Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1993). Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state. Journal of Neuroscience, 13, 1676\u20131687.","journal-title":"Journal of Neuroscience"},{"key":"9036_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1179\/135100099101534701","volume":"4","author":"A. K. Raina","year":"1999","unstructured":"Raina, A. K., Templeton, D. J., Deak, J. C., Perry, G., & Smith, M. A. (1999). Quinone reductase NQO1, a sensitive redox indicator, is increased in Alzheimer\u2019s disease. Redox Report, 4, 23\u201327.","journal-title":"Redox Report"},{"key":"9036_CR22","first-page":"339","volume":"9","author":"A. M. Rauth","year":"1997","unstructured":"Rauth, A. M., Goldberg, Z., & Misra, V. (1997). DT-diaphorase: Possible roles in cancer chemotherapy and carcinogenesis. Oncology Research, 9, 339\u2013349.","journal-title":"Oncology Research"},{"key":"9036_CR23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0197-4580(03)00117-9","volume":"5","author":"K. S. SantaCruz","year":"2004","unstructured":"SantaCruz, K. S., Yazlovitskaya, E., Collins, J., Johnson, J., & DeCarli, C. (2004). Regional NAD(P)H:quinone noxidoreductase activity in Alzheimer\u2019s disease. Neurobiology of Aging, 5, 63\u201369.","journal-title":"Neurobiology of Aging"},{"key":"9036_CR24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00008571-199706000-00008","volume":"7","author":"W. A. Schulz","year":"1997","unstructured":"Schulz, W. A., Krummeck, A., Rosinger, I., et al. (1997). Increased frequency of a null-allele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics, 7, 235\u2013239.","journal-title":"Pharmacogenetics"},{"key":"9036_CR25","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1073\/pnas.96.14.7624","volume":"96","author":"M. T. Smith","year":"1999","unstructured":"Smith, M. T. (1999). Benzene, NQO1, and genetic susceptibility to cancer. Proceedings of the National Academy of Sciences of the United States of America, 96, 7624\u20137626.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9036_CR26","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3324\/haematol.10260","volume":"92","author":"M. Stanulla","year":"2007","unstructured":"Stanulla, M., Dynybil, C., Bartels, D. B., D\u00f6rdelmann, M., et al. (2007). The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: A matched-pair analysis from the ALL-BFM study group. Haematologica, 92, 1581\u20131582.","journal-title":"Haematologica"},{"key":"9036_CR27","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1073\/pnas.92.11.4725","volume":"92","author":"W. J. Strittmatter","year":"1995","unstructured":"Strittmatter, W. J., & Roses, A. D. (1995). Apolipoprotein E and Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 92, 4725\u20134727.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9036_CR28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0079-6123(08)61964-0","volume":"101","author":"R. D. Terry","year":"1994","unstructured":"Terry, R. D. (1994). Neuropathological changes in Alzheimer disease. Progress in Brain Research, 101, 383\u2013390.","journal-title":"Progress in Brain Research"},{"key":"9036_CR29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/bjc.1997.11","volume":"75","author":"R. D. Traver","year":"1997","unstructured":"Traver, R. D., Siegel, D., Beall, H. D., et al. (1997). Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT-diaphorase). British Journal of Cancer, 75, 69\u201375.","journal-title":"British Journal of Cancer"},{"key":"9036_CR30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neulet.2006.09.042","volume":"409","author":"B. B. Wang","year":"2006","unstructured":"Wang, B. B., Jin, F., Xie, Y. C., et al. (2006). Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C\/T polymorphism with Alzheimer\u2019s disease. Neuroscience Letters, 409, 179\u2013181.","journal-title":"Neuroscience Letters"},{"key":"9036_CR31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0197-4580(00)00114-7","volume":"21","author":"Y. Wang","year":"2000","unstructured":"Wang, Y., Santa-Cruz, K., DeCarli, C., & Johnson, J. A. (2000). NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer\u2019s disease. Neurobiology of Aging, 21, 525\u2013531.","journal-title":"Neurobiology of Aging"},{"key":"9036_CR32","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/0140-6736(91)92823-K","volume":"337","author":"P. R. Wenham","year":"1991","unstructured":"Wenham, P. R., Price, W. H., & Blandell, G. (1991). Apolipoprotein E genotyping by one-stage PCR. Lancet, 337, 1158\u20131159.","journal-title":"Lancet"},{"key":"9036_CR33","first-page":"4095","volume":"59","author":"J. L. Wiemels","year":"1999","unstructured":"Wiemels, J. L., Pagnamenta, A., Taylor, G. M., Eden, O. B., Alexander, F. E., & Greaves, M. F. (1999). A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Research, 59, 4095\u20134099.","journal-title":"Cancer Research"},{"key":"9036_CR34","first-page":"1849","volume":"25","author":"B. A. Yankner","year":"1991","unstructured":"Yankner, B. A., & Mesulam, M. M. (1991). Seminars in medicine of the Beth Israel Hospital, Boston. Beta-amyloid and the pathogenesis of Alzheimer\u2019s disease. New England Journal of Medicine, 25, 1849\u20131857.","journal-title":"New England Journal of Medicine"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-008-9036-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-008-9036-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-008-9036-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T13:57:17Z","timestamp":1588341437000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-008-9036-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["9036"],"URL":"https:\/\/doi.org\/10.1007\/s12031-008-9036-z","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,6]]}}}